Related Experiment Videos
[Antipyrine clearance in liver resections]
M T Fiorentini1, M Fracchia, A M Biondi
1Divisioni di Gastroenterologia, Ospedale Mauriziano Umberto, Torino.
Minerva Dietologica E Gastroenterologica
|October 1, 1990
Summary
Antipyrine clearance (APC1) effectively measures residual liver function in patients, especially those with cirrhosis. However, it offers no additional surgical risk insight beyond the established Pugh
Area of Science:
- Hepatology
- Pharmacology
- Surgical Oncology
Background:
- Liver cirrhosis significantly impairs hepatic function.
- Partial hepatectomy is a common treatment for liver tumors, impacting liver function.
- Assessing residual hepatic function is crucial for patient management.
Purpose of the Study:
- To evaluate antipyrine clearance (APC1) as a measure of residual hepatic function.
- To determine if APC1 is a useful index of surgical risk in cirrhotic patients undergoing liver resection.
- To correlate APC1 with established markers of liver health and surgical risk.
Main Methods:
- Antipyrine clearance (APC1) was measured in healthy controls, cirrhotic patients, and patients undergoing partial hepatectomy.
- APC1 was compared between groups and correlated with albumin, pseudocholinesterase, and Pugh's score.
- Statistical analysis was performed to assess significance.
Main Results:
- APC1 was significantly reduced in cirrhotic patients compared to healthy controls.
- APC1 decreased after partial hepatectomy in both cirrhotic and non-cirrhotic patients.
- APC1 showed correlations with albumin, pseudocholinesterase, and Pugh's score.
Conclusions:
- Antipyrine clearance (APC1) is a reliable indicator of residual hepatic function.
- APC1 does not offer superior information for surgical risk assessment compared to the Pugh's score in liver resection.
- APC1 aids in understanding the functional impact of liver disease and surgery.